Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases April 01, 2024 Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development March 18, 2024 Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium March 13, 2024 RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview March 7, 2024 5 MB Roche’s First Quarter Sales 2024 Presentation 4.3 MB 2024 Angiogenesis Meeting Presentation 1.6 MB Fourth Quarter 2023 Financial Results Earnings Call Mar 7, 2024 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
April 01, 2024 Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
March 18, 2024 Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
March 13, 2024 RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Fourth Quarter 2023 Financial Results Earnings Call Mar 7, 2024 at 4:30 PM EST Click here for webcast